Medical/Pharmaceuticals

New FDI World Dental Federation Care Pathway Promotes Dentist-patient Collaboration to Manage Partial Tooth Loss

SAN FRANCISCO, Sept. 5, 2019 /PRNewswire/ -- Today during the ADA FDI World Dental Congress inSan Francisco, USA, FDI World Dental Federation (FDI) released its latest resources on the treatment and care of patients with partial tooth loss. Rather than losing all their teeth as they age, more an...

2019-09-05 14:00 716

Berkeley Lights Opens Shanghai Location

- Nobel Laureate, Professor James E. Rothman, PhD, to speak at all-day symposium onSeptember 5th - China Rep Office located in one of China's leading high-tech industry clusters SHANGHAI and EMERYVILLE, California, Sept. 5, 2019 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a pioneer and leader ...

2019-09-05 08:06 777

Frost & Sullivan Recognizes Validic™ as the North America Customer Value Leader in the Remote Patient Monitoring Market

SANTA CLARA, California, Sept. 4, 2019 /PRNewswire/ -- Based on its recent analysis of the North American remote patient monitoring (RPM) market, Frost & Sullivan recognizesValidic™ with the 2019 North America Customer Value Leadership Award for best meeting the current and future market needs fo...

2019-09-04 21:00 839

CROMSOURCE Continues US Growth With New Office in Research Triangle Park

CARY, North Carolina, Sept. 4, 2019 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO) has just opened a newly expanded office inCary, NC. Due to the growth of CROMSOURCE in the United States over the past few years, this new location serves as a complement to two ...

2019-09-04 21:00 826

IDTechEx Research: The Future of Wearables is Medical

BOSTON, Sept. 4, 2019 /PRNewswire/ -- Wearable technology and medical devices have many prominent synergies. Electronic devices on the body are perfectly placed for sensors to collect data relevant to healthcare, with communication options allowing them to be the gateway to digital health data. C...

2019-09-04 10:00 1247

WuXi AppTec Launches DNA Encoded Library (DEL) Service Package "DELight" to Expedite Early Drug Discovery

SHANGHAI and BOSTON, Sept. 3, 2019 /PRNewswire/ -- WuXi AppTec today announced its launch of DELight, a novel DNA Encoded Library (DEL) service package, providing cost-effective and efficient hit finding services to expedite early drug discovery and bring new medicines to patients faster. DELigh...

2019-09-04 08:00 1093

Porsolt Increases Its Drug Discovery Service Capabilities With the Recent Expansion of Its Research Facility

LAVAL, France, Sept. 4, 2019 /PRNewswire/ -- Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a significant expansion of its research facility, adding a further 5,500 sq.ft. of experimental space.     The expansion integrates Porsolt's new areas of...

2019-09-04 00:03 1214

Strekin AG Secures Financing to Complete Development of STR001 in Sudden Sensorineural Hearing Loss and to Prepare NDA Filing in Europe

BASEL, Switzerland, Sept. 3, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com ), a clinical stage biopharmaceutical company, announced today that it has successfully closed a Series A financing round totalingCHF 2.82 Million from private investors. These funds will enable ...

2019-09-03 14:00 1611

Polpharma Biologics Announces Global Commercialization Deal for Biosimilar Natalizumab, a Key Multiple Sclerosis Medicine

GDAŃSK, Poland, Sept. 3, 2019 /PRNewswire/ -- Polpharma Biologics S.A. ("Polpharma Biologics") today announces that it has entered a global commercialization agreement with Sandoz AG for a natalizumab biosimilar. The medicine is currently in Phase III clinical development for the treatment of re...

2019-09-03 13:15 1530

The First Asia Pacific Psychiatry Symposium Takes Place

SHANGHAI, Sept. 3, 2019 The first-ever Asia Pacific Psychiatric Conference hosted by the Luye Pharma Group recently took place inNanjing. Dozens of psychiatrists and experts from 8 countries and regions includingChina, Korea, Malaysia, and Thailand gathered at the conference to hold discussions o...

2019-09-03 13:11 1441

The First Asia Pacific Psychiatry Symposium Takes Place

NANJING, China, Sept. 3, 2019 /PRNewswire/ -- The first-ever Asia Pacific Psychiatric Conference hosted by the Luye Pharma Group recently took place in Nanjing. Dozens of psychiatrists and experts from 8 countries and regions includingChina, Korea, Malaysia, and Thailand gathered at the conference...

2019-09-03 12:44 1506

International Atherosclerosis Society & Residual Risk Reduction Initiative Publish Consensus Statement on New Treatment for Residual Cardiovascular Risk

MILAN and BASEL, Switzerland, Sept. 3, 2019 /PRNewswire/ -- A new highly selective treatment, a peroxisome proliferator-activated receptor alpha modulator (SPPARM-alpha) agonist, may help to address the gap in managing the residual risk of heart attacks and strokes in high-risk patients, accordin...

2019-09-03 07:44 1284

Children's Lives Will Be Saved Due to Invention of Simple Water Treatment System "Aquatabs Flo"

WEXFORD, Ireland, Sept. 2, 2019  /PRNewswire/ -- The world famous medical journalThe Lancet has published the results of a two year health impact trial in Bangladesh. Less than 5% of studies submitted to this peer reviewed journal are published.  

2019-09-02 21:59 1407

CARsgen Therapeutics Receives US FDA Orphan Drug Designation For Fully Human Anti-BCMA (B Cell Maturation Antigen) Autologous Chimeric Antigen Receptor (CAR) T Cells For The Treatment Of Multiple Myeloma

SHANGHAI, Aug. 30, 2019 /PRNewswire/ -- CARsgen Therapeutics Inc., a clinical-stage biopharmaceutical company today announced the United States Food and Drug Administration (FDA) has granted orphan drug designation to its investigational CAR-T cell therapy fully human anti-BCMA (B Cell Maturation...

2019-08-31 10:54 1709

Syntellix Asia and Chunli Agree Far-reaching Co-operation to Introduce and Market Innovative "Quantum Leap in Implantology" MAGNEZIX® Medtech Devices in China

- Milestone contract signed between leading Chinese orthopaedic medtech supplier andSingapore based Asian subsidiary and hub of German world-market and technology leader in the area of bioabsorbable metallic implants for use in orthopaedic and trauma surgery - Contract volume of more than 100 mi...

2019-08-30 22:28 1737

Innovent Biologics Study Results of IBI303 in Patients with Ankylosing Spondylitis was Published in "The Lancet Rheumatology"

SUZHOU, China, Aug. 30, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the clinical trial results of IBI303, an anti-tumor necrosis factor-alpha (anti-TNF...

2019-08-30 17:38 2427

Concept Medical Inc. Granted 'Breakthrough Device Designation' From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon

Concept Medical Inc. (CMI) has been granted "Breakthrough Device Designation" from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of stenotic lesions of Arteriovenous Fistulae or Arteriovenous graft in hemodialys...

2019-08-30 05:05 1665

DarwinHealth Announces Compound-2-Clinic (C2C) Scientific Collaboration with Celgene to Deploy a Quantitative Systems Biology Discovery Platform to Characterize Celgene Oncology Compounds

NEW YORK, Aug. 30, 2019 /PRNewswire/ -- DarwinHealth today announced a multi-year scientific research collaboration with Celgene Corporation ("Celgene") to use quantitative systems biology-based algorithms, technologies that also underpin NY State CLIA-approved diagnostic tests in oncology, and ...

2019-08-30 01:59 1815

Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India

WETTEREN, Belgium, Aug. 29, 2019 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, announced today its intention to purchase the remaining 50 percent ownership interest in its Visakhapatnam,In...

2019-08-29 20:04 1696

Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines

SHANGHAI, Aug. 29, 2019 /PRNewswire/ -- Luye Pharma Group (02186.HK) released its financial results for the first half of 2019 onAugust 28. The results show the company has achieved a revenue ofRMB 3.131 billion, up 42.1% year-on-year; EBITDA reachedRMB 1.263 billion, up 44.1% year-on-year, while...

2019-08-29 16:34 11030
1234567 ... 343